AGL

agilon health, Inc. is a United States–based company operating in the healthcare sector within the industry of value-based care, medical-services integration and population-health management.

The company provides a comprehensive platform that enables independent physician groups to transition from fee-for-service models to value-based payment structures, primarily within the Medicare Advantage ecosystem.

Founded in 2016, agilon emerged during a national shift toward coordinated care, prevention-focused clinical models and cost-efficiency in the U.S. healthcare system. Its founding mission was to supply the infrastructure, analytics, administrative support and financial frameworks required for independent physicians to manage risk and improve patient outcomes.

The company’s portfolio includes a population-health management platform, clinical-support tools, data analytics, risk-management systems, patient-navigation programs, chronic-care support, operational administration, contracting infrastructure and digital solutions that help medical groups standardize protocols and track outcomes.

The company operates across multiple states in the United States, serving regional physician networks in markets with high Medicare Advantage penetration. 

Market forces affecting agilon’s operations include demographic aging, Medicare Advantage growth, regulatory changes, rising medical-cost trends, increased adoption of value-based payment models, competition among healthcare-services platforms, digital-health evolution and the need for scalable care-management technologies.

Broader healthcare shifts such as chronic-disease prevalence, telehealth expansion, and demand for preventive and coordinated care also shape the company’s strategy.

agilon health, Inc.’s shares trade on the New York Stock Exchange (NYSE) under the ticker AGL.

History and when agilon health, Inc. was founded

agilon health was founded in 2016 with the goal of supporting independent physicians in adopting value-based care and managing clinical and financial risk more effectively. At the time, U.S. healthcare policy and market forces increasingly promoted payment models tied to outcomes, creating demand for platforms capable of integrating analytics, clinical workflow support and contracting structures.

In its early years, the company focused on developing a robust technological and operational framework designed to support Medicare Advantage patient populations. It partnered with regional medical groups to pilot and refine tools for chronic-care management, predictive analytics and risk-adjusted performance.

Between 2018 and 2020, agilon broadened its geographic reach, onboarding additional physician organizations and enhancing its care-management capabilities. The company solidified its operational model, emphasizing collaboration with local practices while providing centralized expertise in analytics and administration.

In 2021, agilon completed its Initial Public Offering (IPO), raising capital to accelerate technology investment, expand into new states and strengthen its market position. The IPO marked a pivotal moment in the company’s growth, enabling more rapid deployment of infrastructure for physician partners across the country.

From 2020 to 2024, agilon operated in an environment shaped by pandemic-related care challenges, rising demand for Medicare Advantage services and increased focus on chronic-disease management.

The company expanded digital capabilities, refined risk-management methodologies, enhanced quality-metric monitoring and broadened partnerships with physician groups. It also adapted to shifts in medical cost structures and evolving regulatory expectations.

By 2024, agilon health had established itself as a major platform for independent physicians operating under value-based care arrangements, providing integrated tools that improve patient outcomes, reduce fragmentation and support sustainable medical-practice growth.

Additional Information

The Company agilon health Inc (United States), is listed on Nasdaq with a market value of $ 4.46 Billions, having an equity of $ 126.73 Millions.

The Company is listedthe in the sector of Others and categorized in industry of Others.

In the last 12 months the Company had a revenue of $ 5.93 Billions, which generated a loss in the amount of $ -391.35 Millions.

As for its main indicators, the Company has a P/E ratio of -11.39, a P/BV ratio of 35.17 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker AGL.